Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Published on by Infectious

Mr. Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Lecturer | Debre Tabor University | Ethiopia 

Dr. Chalachew Yenew Dinku is an accomplished Lecturer and Researcher at Debre Tabor University, Ethiopia, specializing in Environmental and Public Health, with a research focus on environmental and occupational exposure, antimicrobial resistance (AMR), infection prevention and control, One Health, and public health emergency management. He holds a Master of Science in Environmental Health Sciences from Jimma University, where his thesis on AMR contamination pathways received an international research grant and resulted in multiple peer-reviewed publications. He earned his Bachelor of Science in Environmental and Occupational Health and Safety from the University of Gondar, where his undergraduate research on hospital indoor bacterial contamination gained national recognition. With over nine years of professional experience, Dr. Yenew has held key academic and public health roles, including as a Public Health Emergency Surveillance Officer with the Ohio State University Global One Health Initiative and as a Public Health Officer under the Amhara Health Bureau, where he led health education, surveillance, and community health initiatives. At Debre Tabor University, he has served as a member of research committees, supervised postgraduate students, and secured major institutional research grants such as “Addressing Antimicrobial Resistance through a One Health Approach” and “Scabies Screening and Prevention”. Dr. Yenew has authored or co-authored over 55 scientific papers, with 35 published in reputable international journals, 15 as first or corresponding author, and several under review. His extensive editorial contributions include serving as an editor for BMC Public Health, a reviewer for multiple high-impact journals, and a conference presenter at more than 20 national and international scientific events. His research integrates advanced statistical and molecular approaches to tackle pressing public health challenges, bridging academia, policy, and practice. With 355 citations, 47 indexed documents, and an h-index of 9, Dr. Chalachew Yenew exemplifies scholarly excellence, leadership, and commitment to advancing sustainable, evidence-based One Health solutions globally.

Profiles: Scopus | ORCID

Featured Publications

1. Anteneh, R. M., Gashu, Z. E., Baffa, L. D., Bitew, D. A., Yenew, C., Demissie, K. A., Terefe, B., Jejaw, M., Zegeye, A. F., Tiruneh, M. G., et al. (2025). Decomposing socioeconomic and educational inequalities in infant mortality in Sub-Saharan Africa. BMC Public Health, 25(12), 1–12.

2. Mehari, M. G., Yeshiwas, A. G., Esubalew, D., Azmeraw, Y., Delie, A. M., Limenh, L. W., Worku, N. K., Hailu, M., Melese, M., Abie, A., et al. (2025). Dominance of antimicrobial resistant bacteria and risk factors of bacteriuria infection among pregnant women in East Africa. Journal of Health, Population and Nutrition, 25(12), 1–12.

3. Temesgen, A., Anteneh, R. M., Yeshiwas, A. G., Bayeh, G. M., Yenew, C., Ejigu, A. G., Gebeyehu, A. A., Tsega, T. D., Ahmed, A. F., Yemata, G. A., et al. (2025). Systematic review and meta-analysis on gaps in household waste management practices in urban Ethiopia for supporting the TSEDU Ethiopia initiative. Discover Sustainability, 25(12), 1–12.

4. Tsega, T. D., Tsega, S. S., Gebeyehu, A. A., Yemata, G. A., Anteneh, R. M., Yeshiwas, A. G., Yirdaw, G., Yenew, C., Enawgaw, A. S., Ejigu, A. G., et al. (2025). Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa. BMC Infectious Diseases, 25(12), 1–12.

Achilleas Livieratos | Infectious Diseases Vaccines | Best Researcher Award

Published on by Infectious

Dr. Achilleas Livieratos | Infectious Diseases Vaccines | Best Researcher Award

Medical Researcher | Stanford University | Greece

Dr. Achilleas Livieratos, PhD, MRSB, is a distinguished biomedical researcher whose work bridges immunology, infectious diseases, circadian biology, and artificial intelligence applications in health sciences. His research integrates advanced computational methods, including machine learning and multi-agent transformer frameworks, to enhance evidence generation, vaccine immunology, and drug safety analytics. He has published extensively in leading journals such as Vaccines, Pathogens, Viruses, eClinicalMedicine, and Value in Health, contributing to global understanding of immune response dynamics, precision medicine, and outcomes research. Notably, his development of MetaMind, an AI-driven framework for automated network meta-analyses, and his studies on circadian influences on influenza vaccine immunity have been recognized as groundbreaking contributions. His investigations into immune durability across respiratory viruses, including RSV, SARS-CoV-2, and influenza, as well as his exploration of alternative therapies for long COVID, have significantly advanced clinical and translational knowledge. As a lead collaborator with Stanford University and the University of California, San Francisco, Dr. Livieratos has directed international research initiatives on infectious disease modeling, biomarker discovery, and the application of AI in health outcomes research. His earlier work at the University of Oxford produced landmark discoveries in neurogenetics and circadian disruption, underpinning his multidisciplinary expertise. Through leadership in European Pharma and AI consortia, he continues to drive innovation in predictive health analytics and precision therapeutics, demonstrating an exceptional fusion of biomedical insight, computational innovation, and translational research impact.

Profiles : Google Scholar | Scopus

Featured Publication

Oliver, P. L., Sobczyk, M. V., Maywood, E. S., Edwards, B., Lee, S., Livieratos, A., et al. (2012). Disrupted circadian rhythms in a mouse model of schizophrenia. Current Biology, 22(4), 314–319.

Taylor, T. N., Potgieter, D., Anwar, S., Senior, S. L., Janezic, S., Threlfell, S., Ryan, B., et al. (2014). Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse. Neurobiology of Disease, 62, 193–207.

Wobst, H. J., Denk, F., Oliver, P. L., Livieratos, A., Taylor, T. N., Knudsen, M. H., et al. (2017). Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy. Scientific Reports, 7(1), 43198.

Livieratos, A., Gogos, C., & Akinosoglou, K. (2024). Impact of prior COVID-19 immunization and/or prior infection on immune responses and clinical outcomes. Viruses, 16(5), 685.

Livieratos, A., Gogos, C., & Akinosoglou, K. (2024). Beyond antivirals: Alternative therapies for long COVID. Viruses, 16(11), 1795.

Sanaz Ahmadi | Diagnosis of Infectious Diseases | Best Researcher Award

Published on by Infectious

Dr. Sanaz Ahmadi | Diagnosis of Infectious Diseases | Best Researcher Award

Researcher | Academic Center for Education, Culture and Research | Iran

Dr. Sanaz Ahmadi Ghezeldasht is a distinguished researcher and molecular biologist at the Molecular Biology Section, Central Laboratory ACECR, Mashhad, Iran, specializing in medical immunology, molecular virology, and infectious diseases. She holds a Ph.D. in Medical Immunology from Mashhad University of Medical Sciences, an M.Sc. in Animal Physiology from Payam-e-Noor University of Isfahan, and a B.Sc. in Biology from Ferdowsi University of Mashhad. Dr. Ghezeldasht has served as the Supervisor of the Molecular Biology Center at Jahad Daneshgahi Mashhad, contributing to several national and international research projects focused on HTLV-1 pathogenesis, viral immunology, and host-virus interactions. Her prolific research portfolio encompasses numerous peer-reviewed publications in high-impact journals such as Reviews in Medical Virology, Journal of NeuroVirology, and Applied Biochemistry and Biotechnology, highlighting novel insights into viral oncogenesis, molecular diagnostics, and therapeutic development. A dedicated academic leader, she has organized and contributed to multiple scientific congresses and health monitoring initiatives. Dr. Ghezeldasht’s expertise extends to genetic engineering, bioinformatics, PCR technologies, and cell culture, complemented by certifications in English proficiency and advanced computer literacy. She is an active member of the HTLV-I Foundation and the Research Center for HIV/AIDS, HTLV, and Viral Hepatitis at ACECR, reflecting her enduring commitment to advancing molecular medicine and public health. Her scholarly impact is reflected by 409 citations across 26 publications with an h-index of 10.

Profiles: Scopus | ORCID

Featured Publication

1. Shafaei, A., Talebi, K., Zarean, M., Mosavat, A., Khajedaluee, A. R., Afzalaghaee, M., Shamsian, S. A. A., & Ghezeldasht, S. A. (2025). Intestinal parasitic infections, eosinophilia, and Th1/Th2 immune profiles in haemodialysis patients. Parasite Immunology.

2. Rahimzada, M., Nahavandi, M., Saffari, M., Shafaei, A., Mosavat, A., Ghezeldasht, S. A., Ariaee, N., Valizadeh, N., Rahimi, H., Rezaee, S. A., et al. (2023). Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia/lymphoma (ATLL). Molecular Biology Reports, 50(9).

3. Yousefpoor, N., Mahdavian, M., Pourbagher, Z., Ghezeldasht, S. A., Mosavat, A., Ziaee, M., Bahreini, M., Soleimanpour, S., Sharifmoghadam, M. R., Valizadeh, N., et al. (2023). Role of host immunity and HBx among inactive chronic hepatitis B patients in a highly endemic region. Microbial Pathogenesis, 180, 106170.

4. Ghezeldasht, S. A., Bidkhori, H. R., Miri, R., Baghban, A., Mosavat, A., & Rezaee, S. A. (2023). Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo. Journal of NeuroVirology, 29(4), 567–578.

Prof. Dr.Yun Xiang | Infectious Diseases | Best Researcher Award

Published on by Infectious

Prof. Dr.Yun Xiang | Infectious Diseases | Best Researcher Award

Huazhong University of Science & Technology | China.

Author Profile

Scopus

Orcid

🎓Education

Dr. Yun Xiang holds a Ph.D. in Magnetic Resonance Imaging & Spectroscopy from the Wuhan Institute of Physics & Mathematics, Chinese Academy of Sciences (2007). He earned his M.M.D. in Human Anatomy & Histology from Tongji Medical College, Huazhong University of Science & Technology (2002) and a B.M.D. in Clinical Medicine from Tongji Medical University (1991). Further enhancing his expertise, he completed postdoctoral research at the Molecular Imaging Branch, National Institute of Mental Health (NIMH), NIH, USA (2008–2011), focusing on advanced imaging techniques.

💼Professional Experience

Dr. Yun Xiang is a Director and Professor at the Department of Laboratory Medicine, Wuhan Children’s Hospital, Tongji Medical College (2011–Present), where he leads research and clinical advancements in laboratory medicine. He previously served as a Research Scholar at the National Institute of Mental Health (NIMH), NIH, USA (2008–2011), contributing to groundbreaking work in molecular imaging. His academic career includes a tenure as an Associate Professor at Jianghan University’s Medical College (2007–2008). Earlier in his career, he gained extensive clinical experience as a Doctor of Pathology Diagnosis at Tongji Hospital & Wuhan Children’s Hospital (1997–1999) and as a Surgeon & Resident Physician at Renmin Hospital of Laifeng (1991–1994), where he honed his expertise in pathology and surgical procedures.

📚Academic Cites

Dr. Xiang has contributed to numerous peer-reviewed publications and research projects in medical imaging, pathology, and molecular diagnostics. His work has been cited extensively in the fields of pediatric laboratory medicine and neuroimaging.

🧑‍🔬Technical Skills 

Dr. Yun Xiang possesses expertise in Magnetic Resonance Imaging (MRI) & Spectroscopy, applying advanced imaging techniques for medical diagnostics and research. His skills extend to Medical Diagnostics & Pathology Analysis, ensuring accurate disease identification and treatment planning. He has made significant contributions to Molecular Imaging & Mental Health Research, particularly during his tenure at the NIH. Additionally, his proficiency in Clinical Laboratory Medicine & Pediatric Healthcare strengthens his role in advancing diagnostic technologies and improving child health outcomes.

📚Teaching Experience

Dr. Yun Xiang has a strong background in medical education, having taught Human Anatomy & Medical Imaging Theory at Jianghan University’s Medical College, where he trained future medical professionals in advanced diagnostic techniques. His expertise in Pathology & Surgical Methods was instrumental at the Wuhan Advanced Study College of Physicians, where he educated aspiring surgeons on disease pathology and surgical techniques. Additionally, he imparted knowledge on Anatomy & Microsurgery Theory at Jianghan University’s School of Medicine, equipping students with essential skills for precision-based surgical procedures.

🏆Awards & Honors

  • Recognized for outstanding contributions in pediatric laboratory medicine & medical imaging
  • Recipient of national and institutional research grants for advanced studies in MRI & molecular imaging

🔬Research Interests

Dr. Xiang’s research focuses on medical imaging innovations, pediatric laboratory diagnostics, neuroimaging for mental health disorders, and molecular pathology. His contributions continue to drive advancements in clinical diagnostics and patient care.

With a strong interdisciplinary background, Dr. Yun Xiang remains at the forefront of medical research and education, shaping the future of diagnostic medicine and healthcare technology.

📑Notable Publications 

‘Age- and sex-specific reference intervals for sex hormones in children in Wuhan: a cross-sectional study of 2,477 healthy children and adolescents’

Authors: L. Zhao, W. Tuo, J. Wang, C. Yao, Q. Cai
Year: 2025
Journal: Translational Pediatrics

‘Mechanism of Mycobacterium tuberculosis infection mediated by macrophage-derived exosomes following Rv1983 stimulation’

Authors: Q. Cai, C. Yuan, J. Wang, X. Guo, Y. Xiang
Year: 2024
Journal: Chinese Journal of Microbiology and Immunology (China)

‘High prevalence and seasonal patterns of vitamin D deficiency in children and adolescents in Central China: a three-year single-center study’

Authors: L. Xi, X. Wang, J. Rao, Y. Xiang, C. Li
Year: 2024
Journal: Preventive Medicine Reports

‘Epidemiological study of human papillomavirus infection in 105,679 women in Wuhan, China’

Authors: W. Guo, Z. Hu, J. Yan, C. Yao, K. Du
Year: 2024
Journal: BMC Infectious Diseases